Published in Mov Disord on March 29, 2015
FSL. Neuroimage (2011) 15.56
Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal (2007) 13.54
Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol (2011) 2.99
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol (1997) 2.64
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol (2014) 2.48
Registration and machine learning-based automated segmentation of subcortical and cerebellar brain structures. Neuroimage (2007) 2.31
Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet (2011) 2.05
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med (2006) 1.83
Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull (2010) 1.79
Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J Neurochem (2010) 1.73
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain (1996) 1.64
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res (2007) 1.63
Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci (2008) 1.59
Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev (2008) 1.55
Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. Radiology (1999) 1.53
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Front Aging Neurosci (2014) 1.53
Fully automated analysis using BRAINS: AutoWorkup. Neuroimage (2010) 1.52
MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol (Noisy-le-grand) (2000) 1.39
MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol (1993) 1.35
Lactate release from cultured astrocytes and neurons: a comparison. Glia (1988) 1.30
Effects of intracellular pH, blood, and tissue oxygen tension on T1rho relaxation in rat brain. Magn Reson Med (2002) 1.27
Development of biomarkers for Huntington's disease. Lancet Neurol (2011) 1.26
Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism. Hum Mol Genet (2008) 1.14
In vivo measurement of plaque burden in a mouse model of Alzheimer's disease. J Magn Reson Imaging (2006) 1.13
T1rho MRI of Alzheimer's disease. Neuroimage (2008) 1.13
Detecting activity-evoked pH changes in human brain. Proc Natl Acad Sci U S A (2012) 1.11
Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry (2011) 1.09
Robust multi-site MR data processing: iterative optimization of bias correction, tissue classification, and registration. Front Neuroinform (2013) 1.08
Increased basal ganglia iron levels in Huntington disease. Arch Neurol (1999) 1.01
T1rho and T2rho MRI in the evaluation of Parkinson's disease. J Neurol (2010) 1.00
T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia. J Neurol (2010) 0.97
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology (2005) 0.95
Characterization of non-hemodynamic functional signal measured by spin-lock fMRI. Neuroimage (2013) 0.93
Elevated brain iron is independent from atrophy in Huntington's Disease. Neuroimage (2012) 0.93
Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp (2012) 0.93
Early marker for Alzheimer's disease: hippocampus T1rho (T(1rho)) estimation. J Magn Reson Imaging (2009) 0.88
Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study. Hum Brain Mapp (2013) 0.88
MRI measures of corpus callosum iron and myelin in early Huntington's disease. Hum Brain Mapp (2013) 0.87
Reduced functional brain connectivity prior to and after disease onset in Huntington's disease. Neuroimage Clin (2013) 0.87
pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. J Cereb Blood Flow Metab (2012) 0.86
Disruption of response inhibition circuits in prodromal Huntington disease. Cortex (2014) 0.84
Trinucleotide repeats in neurologic diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I. Life Sci (1994) 0.84
Precision-guided sampling schedules for efficient T1ρ mapping. J Magn Reson Imaging (2014) 0.82
MRI biomarkers in Huntington's disease. Front Biosci (Elite Ed) (2012) 0.81
The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study. Hum Brain Mapp (2014) 0.81
Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB. Cell Mol Life Sci (2012) 0.78
Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker. Neurology (2014) 0.76
T2-selective magnetization preparation pulses. IEEE Trans Med Imaging (2007) 0.76
Precision-guided sampling schedules for efficient T1ρ mapping. J Magn Reson Imaging (2014) 0.82
Eccentricity mapping of the human visual cortex to evaluate temporal dynamics of functional T1ρ mapping. J Cereb Blood Flow Metab (2015) 0.75